ABEO - Abeona Therapeutics Revenue Dynamics YoY (Last Twelve Months)

FDA Breakthrough Therapy designation protects Abeona Therapeutics (ABEO) from price dumping in the orphan drug sector. The TTM annual revenue trend visualizes the actual state of the business, where 9633.20 shows the level of this metric. Patents for Pz-cel strengthen the company's market moat, while the implementation of ESG standards minimizes the carbon footprint and optimizes water resource utilization in production.
Abeona Therapeutics, Inc. (ABEO) - metric breakdowns and financial figures

This indicator measures the growth rate of annual revenue over a rolling twelve-month period, neutralizing quarterly volatility to identify the true trajectory of business development. Analyzing the percentage change in sales over the last 12 months compared to the previous 12 months allows for an assessment of the commercial efficiency of Abeona Therapeutics (ABEO) in the field of cell therapy development for rare pediatric pathologies and partnerships with research centers.